Matthias Schnell, PhD

Contact Dr. Schnell

1020 Locust Street
Room 309
Philadelphia, PA 19107

(215) 503-4634

Most Recent Peer-reviewed Publications

  1. Retrograde axonal transport of rabies virus is unaffected by interferon treatment but blocked by emetine locally in axons
  2. The spread and evolution of rabies virus: Conquering new frontiers
  3. Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease
  4. Ifit2 is a restriction factor in rabies virus pathogenicity
  5. Progress in Ebola Virus Vaccine Development
  6. Inactivated recombinant rabies viruses displaying canine distemper virus glycoproteins induce protective immunity against both pathogens
  7. The final (Oral Ebola) vaccine trial on captive chimpanzees?
  8. Toward an Effective Ebola Virus Vaccine
  9. One-Health: A safe, efficient, dual-use vaccine for humans and animals against middle east respiratory syndrome coronavirus and rabies virus
  10. Keeping it in check: Chronic viral infection and antiviral immunity in the brain
  11. An Inactivated Rabies Virus-Based Ebola Vaccine, FILORAB1, Adjuvanted with Glucopyranosyl Lipid A in Stable Emulsion Confers Complete Protection in Nonhuman Primate Challenge Models
  12. Rabies Virus CVS-N2cδGStrain Enhances Retrograde Synaptic Transfer and Neuronal Viability
  13. Everything You Always Wanted to Know about Rabies Virus (But Were Afraid to Ask)
  14. Human polyclonal antibodies produced through DNA vaccination of transchromosomal cattle provide mice with post-exposure protection against lethal zaire and Sudan ebolaviruses
  15. Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeutics
  16. Rhabdovirus-based vaccine platforms against henipaviruses
  17. Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine
  18. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses
  19. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs
  20. Recombinant rabies virus particles presenting botulinum neurotoxin antigens elicit a protective humoral response in vivo